Firmagon kit is a prescription medicine containing Degarelix, marketed by Ferring Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C…
Key facts
- Active ingredient (INN)
- Degarelix
- Brand
- Firmagon
- Dosage form
- Kit
- Packs
- 1 kit
- Marketing authorisation holder
- Ferring Pharmaceuticals
- Manufacturer
- Ferring Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L02BX02 Degarelix
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 2 March 2009
- Identifiers
- RxCUI 828749, 828751, 858125 +1DailyMed set ID ab11dd8a-0fd9-4013-89ab-e114557c7e4bNDC 55566-8303, 55566-8403Application NDA022201
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 kit in 1 carton * 4 mL in 1 vial, glass * 4.2 mL in 1 syringe | 55566-8303-1 | Ferring Pharmaceuticals | 2 March 2009 |
| 1 kit in 1 carton * 3 mL in 1 syringe * 3 mL in 1 vial, glass | 55566-8403-1 | Ferring Pharmaceuticals | 2 March 2009 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Degarelix is a prescription medicine indicated for treatment of patients with advanced prostate cancer. It is available as kits. MedsAcross supplies Degarelix for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DegarelixFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- FIRMAGON prescribing information (Ferring Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Firmagon: European public assessment report (EPAR) · European Medicines Agency
- Degarelix Accord: European public assessment report (EPAR) · European Medicines Agency
Need Firmagon kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.